BTG2(TIS21/PC3) induces neuronal differentiation and prevents apoptosis of terminally differentiated PC12 cells

Fatiha el-Ghissassi1, Sandrine Valsesia-Wittmann, Nicole Falette

  • 1Département d'Oncologie Fondamentale et Appliquée, INSERM Unité 453. Centre Léon Bérard, 28 rue Laënnec, 69008, Lyon, France.

Oncogene
|October 3, 2002
PubMed

Insights

BTG2, a gene targeting p53, promotes neuronal differentiation and survival. Overexpressing BTG2 enhances nerve growth factor-induced differentiation, while inhibiting it causes cell death in differentiated neurons.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Molecular Biology

Background:

  • BTG2 (also known as TIS21/PC3) is a p53-transcriptional target previously identified as an antiproliferative gene.
  • The specific roles of BTG2 protein in biological processes, particularly neurogenesis, require further investigation.

Purpose of the Study:

  • To investigate the functional significance of BTG2 during neuronal differentiation.
  • To elucidate the role of BTG2 in the survival of terminally differentiated neuronal cells.

Main Methods:

  • Utilized PC12 cells, a rat pheochromocytoma cell line, for in vitro studies.
  • Employed a vector for inducible overexpression of BTG2 in PC12 cells.
  • Used antisense oligonucleotides to inhibit endogenous BTG2 expression.

Main Results:

  • BTG2 overexpression significantly enhanced nerve growth factor (NGF)-induced growth arrest and neuronal differentiation in PC12 cells.
  • Inhibition of endogenous BTG2 expression using antisense oligonucleotides led to programmed cell death in differentiated PC12 cells.

Conclusions:

  • BTG2 expression plays a crucial role in promoting neuronal differentiation.
  • BTG2 is essential for the survival of terminally differentiated neuronal cells.